Boothbay Fund Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Boothbay Fund Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-45,000	Closed	-$39.1K	–	2233
2023 Q2	$39.1K	Buy	+45,000	New	+$32.1K	﹤0.01%	1690
2021 Q1	–	Sell	-12,793	Closed	-$118K	–	1861
2020 Q4	$118K	Buy	+12,793	New	+$111K	﹤0.01%	1169

Boothbay Fund Management's SURF Position: Q3 2023 in Review

Boothbay Fund Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 45,000 shares — an estimated $39.1K sold.

Boothbay Fund Management first reported a position in SURF in Q4 2020 and held it in 2 quarters. The position peaked at $118K in Q4 2020. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

Boothbay Fund Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Boothbay Fund Management sold 45,000 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $39.1K.
Boothbay Fund Management first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
Boothbay Fund Management's Surface Oncology, Inc. Common Stock position peaked at $118K in Q4 2020.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.